1. Home
  2. ATKR vs AGIO Comparison

ATKR vs AGIO Comparison

Compare ATKR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATKR
  • AGIO
  • Stock Information
  • Founded
  • ATKR 1959
  • AGIO 2007
  • Country
  • ATKR United States
  • AGIO United States
  • Employees
  • ATKR N/A
  • AGIO N/A
  • Industry
  • ATKR Industrial Machinery/Components
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATKR Miscellaneous
  • AGIO Health Care
  • Exchange
  • ATKR Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • ATKR 2.2B
  • AGIO 2.4B
  • IPO Year
  • ATKR 2016
  • AGIO 2013
  • Fundamental
  • Price
  • ATKR $66.12
  • AGIO $41.38
  • Analyst Decision
  • ATKR Hold
  • AGIO Strong Buy
  • Analyst Count
  • ATKR 6
  • AGIO 4
  • Target Price
  • ATKR $81.00
  • AGIO $59.33
  • AVG Volume (30 Days)
  • ATKR 617.6K
  • AGIO 552.6K
  • Earning Date
  • ATKR 11-20-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • ATKR 2.05%
  • AGIO N/A
  • EPS Growth
  • ATKR N/A
  • AGIO N/A
  • EPS
  • ATKR 3.22
  • AGIO 11.13
  • Revenue
  • ATKR $2,886,664,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • ATKR N/A
  • AGIO $23.76
  • Revenue Next Year
  • ATKR N/A
  • AGIO $148.23
  • P/E Ratio
  • ATKR $20.52
  • AGIO $3.67
  • Revenue Growth
  • ATKR N/A
  • AGIO 30.57
  • 52 Week Low
  • ATKR $49.92
  • AGIO $23.42
  • 52 Week High
  • ATKR $105.28
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • ATKR 63.19
  • AGIO 59.53
  • Support Level
  • ATKR $61.83
  • AGIO $39.71
  • Resistance Level
  • ATKR $64.77
  • AGIO $43.21
  • Average True Range (ATR)
  • ATKR 2.08
  • AGIO 1.52
  • MACD
  • ATKR 0.29
  • AGIO 0.07
  • Stochastic Oscillator
  • ATKR 94.25
  • AGIO 72.48

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: